Skip to content
 

A Revolutionary

Regenerative

Biotherapeutic

Treatment

 

Regenerative Biotherapeutic.

 

The Regenerative Biotherapeutic industry is fast becoming the field of choice for innovation and specialised talent alike, due to the abundant need to solve the increasingly prevalent issue of a global aging population.  
A higher and higher proportion of people are experiencing the burden of age-related conditions and chronic diseases, because improvements in healthspanthe period of life spent without infirmities - has not kept pace with improvements in life expectancy.
 
THE AVERAGE 65YR OLD HAS 2 AGE RELATED CONDITIONS OR DISEASES, WITH THE AVERAGE 80YR OLD HAVING 5 OR MORE.
Opera Snapshot_2023-05-25_002438_Exomed-slide-deck_DRAFT_19-04-23 (3).pdf

Revolutionary approach to exosome application

Unlike many in the field chasing deliverables that may still be quite “blue sky” and still years from application, we have developed a solution to be applied TODAY.
We have developed and patented a revolutionary clinical product designed to enhance and extend the quality of life for ageing individuals by driving improvements in healthspan.
Our product directly focuses on “Rebuilding Health” and driving improvements in healthspan.
By targeting the underlying mechanisms of ageing (rather than individual diseases and conditions) and utilizing the regenerative power of our treatment, it makes it possible to restore function to diseased and dysfunctional tissues and improve healthspan.
Our novel approach, utilises a natural food grade product as the basis of our regenerative biotherapeutic treatment. This allows the medication to be positioned and marketed in a category both in Australia and overseas with minimal regulatory hurdles. 
This significantly reduces cost, simplifies processing and substantially speeds the path to market.
We are very excited to launch our product as this burgeoning industry is set to explode, with the market in terms of revenue to be worth $12.2 Billion in back in 2022, is forecasted to reach heights of $40.6 Billion by 2027, growing at a CAGR of 27.2% from 2022 to 2027.

 

exomed

THE FOCUS HAS MOVED FROM

Treating Individual Diseases To "Rebuilding Health"

In what has been described as a massive market, a natural product with no true competitor has enormous potential for market penetration globally.

We are looking to align with financial partners with similar values and strategic objectives.

We are looking to build partnerships that will allow all parties to meet their objectives and are excited to begin building the foundation with the next step of introductory meetings. 
If you feel, we are aligned with your business, please feel free to make contact via the contact form and we will be in touch. Thank you.

 

Exosome.up.close